152 related articles for article (PubMed ID: 8079664)
1. Relationship of the plasminogen activator/plasmin cascade to osteoclast invasion and mineral resorption in explanted fetal metatarsal bones.
Leloup G; Delaisse JM; Vaes G
J Bone Miner Res; 1994 Jun; 9(6):891-902. PubMed ID: 8079664
[TBL] [Abstract][Full Text] [Related]
2. Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor.
Leloup G; Lemoine P; Carmeliet P; Vaes G
J Bone Miner Res; 1996 Aug; 11(8):1146-57. PubMed ID: 8854251
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
Lerner UH
J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
[TBL] [Abstract][Full Text] [Related]
4. Tissue and urokinase plasminogen activators in bone tissue and their regulation by parathyroid hormone.
Leloup G; Peeters-Joris C; Delaisse JM; Opdenakker G; Vaes G
J Bone Miner Res; 1991 Oct; 6(10):1081-90. PubMed ID: 1796756
[TBL] [Abstract][Full Text] [Related]
5. Dose-related effects of 1,25-dihydroxyvitamin D3 on growth, modeling, and morphology of fetal mouse metatarsals cultured in serum-free medium.
Bagi CM; Miller SC
J Bone Miner Res; 1992 Jan; 7(1):29-40. PubMed ID: 1549956
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting and stimulating effects of TGF-beta 1 on osteoclastic bone resorption in fetal mouse bone organ cultures.
Dieudonné SC; Foo P; van Zoelen EJ; Burger EH
J Bone Miner Res; 1991 May; 6(5):479-87. PubMed ID: 2068954
[TBL] [Abstract][Full Text] [Related]
7. The role of the plasminogen system in bone resorption in vitro.
Daci E; Udagawa N; Martin TJ; Bouillon R; Carmeliet G
J Bone Miner Res; 1999 Jun; 14(6):946-52. PubMed ID: 10352103
[TBL] [Abstract][Full Text] [Related]
8. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of 3,5,3'-triiodothyroacetic acid and triiodothyronine on bone resorption in cultured fetal rat long bones and neonatal mouse calvariae.
Kawaguchi H; Pilbeam CC; Woodiel FN; Raisz LG
J Bone Miner Res; 1994 Feb; 9(2):247-53. PubMed ID: 8140938
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone sensitizes long bones to the stimulation of bone resorption by 1,25-dihydroxyvitamin D3.
van Leeuwen JP; Birkenhäger JC; Bos MP; van der Bemd GJ; Herrmann-Erlee MP; Pols HA
J Bone Miner Res; 1992 Mar; 7(3):303-9. PubMed ID: 1585831
[TBL] [Abstract][Full Text] [Related]
11. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
12. Expression of calcitonin receptors during osteoclast differentiation in mouse metatarsals.
Taylor LM; Tertinegg I; Okuda A; Heersche JN
J Bone Miner Res; 1989 Oct; 4(5):751-8. PubMed ID: 2554690
[TBL] [Abstract][Full Text] [Related]
13. Macrophage colony-stimulating factor restores bone resorption in op/op bone in vitro in conjunction with parathyroid hormone or 1,25-dihydroxyvitamin D3.
Morohashi T; Corboz VA; Fleisch H; Cecchini MG; Felix R
J Bone Miner Res; 1994 Mar; 9(3):401-7. PubMed ID: 8191935
[TBL] [Abstract][Full Text] [Related]
14. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
15. The effect of tissue type plasminogen activator (tPA) on osteoclastic resorption in embryonic mouse long bone explants: a possible role for the growth factor domain of tPA.
Hoekman K; Löwik CW; van de Ruit M; Bijvoet OL; Verheijen JH; Papapoulos SE
Bone Miner; 1992 Apr; 17(1):1-13. PubMed ID: 1533805
[TBL] [Abstract][Full Text] [Related]
16. The effects of serine proteinase inhibitors on bone resorption in vitro.
Tumber A; Papaioannou S; Breckon J; Meikle MC; Reynolds JJ; Hill PA
J Endocrinol; 2003 Sep; 178(3):437-47. PubMed ID: 12967336
[TBL] [Abstract][Full Text] [Related]
17. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors.
Amano S; Hanazawa S; Kawata Y; Ohta K; Kitami H; Kitano S
J Bone Miner Res; 1992 Mar; 7(3):321-8. PubMed ID: 1585834
[TBL] [Abstract][Full Text] [Related]
18. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
19. Increased bone formation and decreased bone resorption in fetal mouse calvaria as a result of intermittent compressive force in vitro.
Klein-Nulend J; Veldhuijzen JP; de Jong M; Burger EH
Bone Miner; 1987 Sep; 2(6):441-8. PubMed ID: 3505768
[TBL] [Abstract][Full Text] [Related]
20. Morphology of osteoclasts in resorbing fetal rat bone explants: effects of PTH and AIF in vitro.
Wezeman FH; Kuettner KE; Horton JE
Anat Rec; 1979 Jul; 194(3):311-23. PubMed ID: 224732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
